http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#Head http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#assertion http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#provenance http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#pubinfo http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#assertion http://purl.obolibrary.org/obo/DOID_12098 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_12098 http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00564 http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association http://www.w3.org/2000/01/rdf-schema#label equetro is a mood stabilizer indicated for the treatment of acute manic or mixed episodes associated with bipolar i disorder 1 1 indicated for the treatment of the pain associated with trigeminal neuralgia 1 2 an anti epileptic drug aed indicated for the treatment of partial seizures with complex symptomatology generalized tonic clonic seizures and mixed seizures 1 3 equetro is indicated for treatment of patients with acute manic or mixed episodes associated with bipolar i disorder see clinical studies 14 1 equetro is indicated in the treatment of the pain associated with trigeminal neuralgia beneficial results have also been reported in glossopharyngeal neuralgia this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains equetro is indicated for the treatment of partial seizures with complex symptomatology e g psychomotor temporal lobe generalized tonic clonic seizures grand mal and mixed seizure patterns which include the seizure types listed here or other partial or generalized seizures limitations of usage equetro is not indicated for the treatment of absence seizures petit mal carbamazepine has been associated with increased frequency of generalized convulsions in these patients http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00564 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#provenance http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#pubinfo http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#sig http://purl.org/nanopub/x/hasSignature gtq7UhymlHCLLTyjbwFHbq0kKymwxiQIclReNMFtva+JA5ICrJI40fgrnPM7TLwaqnN7qpV1LfU2J2wU4LHkKVcoMRi5ES7DE21Ka5HrcxCg+crtFdkN06yRzr7UyNB3ZInkFblhcufWbWZPXPb2qqy+yDGMFAJlOfN8qov35+4= http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://purl.org/dc/terms/created 2021-07-03T13:13:55.536+02:00 http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAhWmxcBRTf1WwTKfOV6dgbPPihY5vEacyFx8nCbN18S4 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs